Výsledky vyhledávání - Marcelo Paredes

  • Zobrazuji výsledky 1 - 5 z 5
Upřesnit hledání
  1. 1
    POST-TRANSPLANT HLA ANTIBODIES DETECTED BY LUMINEX DONOR-SPECIFIC CROSSMATCH CORRELATE WITH POOR LIVER GRAFT OUTCOME

    POST-TRANSPLANT HLA ANTIBODIES DETECTED BY LUMINEX DONOR-SPECIFIC CROSSMATCH CORRELATE WITH POOR LIVER GRAFT OUTCOME Autor Francisco Monteiro, H. Rodrigues, Jorge Kalil, Marcelo Paredes, P. Massarolo, Sérgio Mies

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Pre- and Posttransplant Monitoring of Alloantibodies by Complement-Dependent Cytotoxicity and Luminex Methodologies in Liver Transplantation

    Pre- and Posttransplant Monitoring of Alloantibodies by Complement-Dependent Cytotoxicity and Luminex Methodologies in Liver Transplantation Autor Francisco Monteiro, H. Rodrigues, Jorge Kalil, Maria Cristina Ribeiro de Castro, N Panajotopoulos, Marcelo Paredes, P. Massarolo, Sérgio Mies

    Vydáno 2012
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Is Dialysis Responsible for Poorer Outcomes of Liver Transplants in Patients With High MELD Scores (≥30)?

    Is Dialysis Responsible for Poorer Outcomes of Liver Transplants in Patients With High MELD Scores (≥30)? Autor Huda Maria Noujaim, M. de Miranda, L E Ianhez, David Machado, Karine Gadioli Oliveira, Marcelo Paredes, L., Randolfo dos Santos, J. Branhez, Luca Motta, Tércio Genzini

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Outcomes of Liver Transplants for Patients With High MELD Score (≥30).

    Outcomes of Liver Transplants for Patients With High MELD Score (≥30). Autor Huda Maria Noujaim, M. de Miranda, J. Branhez, Luca Motta, Marcelo Paredes, Karini Leal Rolim de Oliveira, L E Ianhez, David Machado, L., Regina Gomes dos Santos, Tércio Genzini

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

    Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial Autor Vlad Ratziu, Ladrón de Guevara, Rifaat Safadi, Fred Poordad, Felipe Fuster, Jose Flores‐Figueroa, Marco Arrese, Anna Ludovica Fracanzani, Dafna Ben Bashat, K. Lackner, Tali Gorfine, Shaul Kadosh, R. Oren, Michael Halperin, Liat Hayardeny, Rohit Loomba, Scott L. Friedman, Manal F. Abdelmalek, Francesco Angelico, M. Angélico, Juan Pablo Arancibia, Edouard Bardou‐Jacquet, Francisco Barrera, Charles F. Barish, Yaacov Baruch, Ziv Ben‐Ari, Thomas Berg, Marc Bourlière, Jérôme Boursier, Efrat Broide, Michal Carmiel, Douglas Denham, L. Di Cesare, Dan L. Dumitrașcu, Adi Francis, Samer Gawrieh, María Saraí González Huezo, Patrick Hillon, A De Molina Iracheta, Zeid Kayali, Limas Kupčinskas, George Lau, Lawrence Serfaty, Aline Le Cleach, C. Loguercio, M.P. Manns, Brittany Saldivar, Edward Mena, Luis Alonso Morales-Garza, J NEUTEL, L R Nikoleishvili, Mazen Noureddin, R. Pais, Alfonso Paredes, Marcelo Paredes, Runa Watkins, Antonio Picardi, Mario Pirisi, Gonzalo Pizarro Jofré, Liliana Preoțescu, Tarek Saadi, Didier Samuel, J.F. Sánchez-Ávila, Ingolf Schiefke, Oren Shibolet, M. Shadab Siddiqui, G. Torres-Mendoza, J.F. Trotter, Eugenia Tsai, Elizabeth C. Verna, E. Zuckerman, Dinah Zur, Arun J. Sanyal

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: